Lisata Therapeutics, Inc. (LSTA)
$1.08+2.86%Close
SELLCRISIS · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10M
- Beta
- 0.80
- P/E (TTM)
- -0.66
- Short % float
- 0.53%
- Days to cover
- 1.0
- SI change
- -76.1%
- 1W
- -10.74%
- 1M
- -30.77%
- vs SPY 1W
- -10.61%
- vs SPY 1M
- -33.28%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on LSTA?
- LOPJLB’s latest quantitative signal on Lisata Therapeutics, Inc. (LSTA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is LSTA in?
- Lisata Therapeutics, Inc. (LSTA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Lisata Therapeutics, Inc. (LSTA) do?
- Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase…